[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617798":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":10,"responsibleParty":25,"collaborators":10,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":31,"acronym":10,"eligibilityCriteria":32,"healthyVolunteers":29,"sex":33,"minAge":34,"maxAge":10,"enrollmentInfo":35,"targetDuration":10,"studyType":38,"phases":10,"briefSummary":39,"conditions":40,"keywords":10,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":10},{"fullName":5,"class":6},"PeriPharm","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient with HS",null,"Patient diagnosed with HS",[13],"Other: No Intervention: Observational Cohort",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"No Intervention: Observational Cohort","No specific intervention is assess in this study. Observational cohort.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Jean Lachaine, PhD","CONTACT","514-731-8207","jean.lachaine@peripharm.com",{"type":26,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100617798","real-world-study-on-the-burden-of-hidradenitis-suppurativa-100617798",false,"NCT07323303","Real-World Study on the Burden of Hidradenitis Suppurativa","Inclusion Criteria:\n\n1. Patient diagnosed with HS;\n2. Aged ≥18 years;\n3. Able to read and understand French or English;\n4. Willing and able to provide written informed consent.\n\nExclusion Criteria:\n\n1\\. Participation in an interventional study for HS.","ALL","18 Years",{"count":36,"type":37},100,"ESTIMATED","OBSERVATIONAL","Despite the significant impact of HS on patients' quality of life (QoL) and daily functioning, there remains limited real-world evidence describing the burden of this condition in Canada. HS is an under-recognized and often misdiagnosed condition, with a substantial psychological and physical burden on patients. Understanding the real-world experiences of individuals living with HS in Canada can help identify unmet needs and inform patient-centered care approaches.",[41],"Hidradenitis Suppurativa (HS)","NOT_YET_RECRUITING","2025-12-22",{"date":45,"type":46},"2026-01-07","ACTUAL",{"date":48,"type":37},"2026-01",{"date":50,"type":37},"2026-07",{"name":5,"class":6}]